HUP9702448A2 - Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény - Google Patents

Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény

Info

Publication number
HUP9702448A2
HUP9702448A2 HU9702448A HUP9702448A HUP9702448A2 HU P9702448 A2 HUP9702448 A2 HU P9702448A2 HU 9702448 A HU9702448 A HU 9702448A HU P9702448 A HUP9702448 A HU P9702448A HU P9702448 A2 HUP9702448 A2 HU P9702448A2
Authority
HU
Hungary
Prior art keywords
carboxylic acid
indole
pharmaceutical composition
parenteral application
application containing
Prior art date
Application number
HU9702448A
Other languages
English (en)
Inventor
Andrea Lodi
Maria Teresa Rossato
Original Assignee
Glaxo Wellcome S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome S.P.A. filed Critical Glaxo Wellcome S.P.A.
Publication of HUP9702448A2 publication Critical patent/HUP9702448A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya gyógyászati készítmény parenterális adagőlásraalkalmas főrmában, amely (E)-3-[2-(fenil-karbamőil)-etenil]-4,6-diklór-indől-2-karbőnsav glicin-antagőnista vagy annak fiziőlógiásanelfőgadható sója őldatát tartalmazza a vegyület egy vízzel elegyedőszerves őldószerét tartalmazó izőtóniás cűkőrőldatban, a készítménypH-ja 7 és 9 közötti. ŕ
HU9702448A 1995-02-11 1996-02-08 Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény HUP9702448A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9502695.1A GB9502695D0 (en) 1995-02-11 1995-02-11 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
HUP9702448A2 true HUP9702448A2 (hu) 1999-10-28

Family

ID=10769456

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9702448A HUP9702448A2 (hu) 1995-02-11 1996-02-08 Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény

Country Status (18)

Country Link
US (2) US5886018A (hu)
EP (1) EP0809514A1 (hu)
JP (1) JPH10513464A (hu)
KR (1) KR19980702109A (hu)
AU (1) AU707220B2 (hu)
BR (1) BR9607433A (hu)
CA (1) CA2212041A1 (hu)
CZ (1) CZ252897A3 (hu)
EA (1) EA000211B1 (hu)
FI (1) FI973280A0 (hu)
GB (1) GB9502695D0 (hu)
HU (1) HUP9702448A2 (hu)
IL (1) IL117098A0 (hu)
NO (1) NO973656L (hu)
NZ (1) NZ300937A (hu)
PL (1) PL321734A1 (hu)
WO (1) WO1996024376A1 (hu)
ZA (1) ZA961051B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
US20030162825A1 (en) * 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US20040019075A1 (en) * 2002-05-29 2004-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New formulation for the parenteral application of crobenetine
NZ548212A (en) 2003-12-29 2010-07-30 Sepracor Inc Pyrrole and pyrazole DAAO inhibitors
WO2006095363A2 (en) 2005-02-01 2006-09-14 Troikaa Pharmaceuticals Ltd Injectable preparations of diclofenic and its pharmaceutically acceptable salts
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
MX2019015120A (es) 2017-06-12 2022-07-14 Glytech Llc Composicion y metodo para el tratamiento de la depresion y psicosis en humanos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物
ES2088011T3 (es) * 1990-07-16 1996-08-01 Merrell Pharma Inc Antagonistas de aminoacidos excitadores.
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition

Also Published As

Publication number Publication date
WO1996024376A1 (en) 1996-08-15
ZA961051B (en) 1996-09-11
IL117098A0 (en) 1996-06-18
EA199700095A1 (ru) 1998-02-26
MX9706044A (es) 1998-06-28
AU707220B2 (en) 1999-07-08
US6020359A (en) 2000-02-01
NZ300937A (en) 1999-02-25
NO973656D0 (no) 1997-08-08
KR19980702109A (ko) 1998-07-15
FI973280A (fi) 1997-08-08
CZ252897A3 (cs) 1998-03-18
EP0809514A1 (en) 1997-12-03
GB9502695D0 (en) 1995-03-29
PL321734A1 (en) 1997-12-22
FI973280A0 (fi) 1997-08-08
US5886018A (en) 1999-03-23
NO973656L (no) 1997-10-08
AU4622896A (en) 1996-08-27
JPH10513464A (ja) 1998-12-22
CA2212041A1 (en) 1996-08-15
BR9607433A (pt) 1998-05-26
EA000211B1 (ru) 1998-12-24

Similar Documents

Publication Publication Date Title
HUP9802999A2 (hu) N-propargil-1-amino-indánt tartalmazó gyógyszerkészítmény
NO306725B1 (no) Ny krystallmodifikasjon av CDCH, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende denne samt anvendelse av forbindelsen for fremstilling av legemidler
HUP9802221A2 (hu) Parazitaellenes hatású markfortin- és paraherkvamidszármazékok
SE9504661D0 (sv) New compounds
CA2356310A1 (en) External preparations containing a basic drug
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
ATE202337T1 (de) Cyclopropylalkansäurederivate
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
HUP0001293A1 (hu) Heterociklusos vegyületek és ezeket tartalmazó gyógyászati készítmények béta-amiloid-peptidek gátlására
HUP9901586A2 (hu) Antifungális szert és acetátpuffert tartalmazó készítmények és alkalmazásuk
SE9700885D0 (sv) New pharmaceutical formulation
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
DE69317877T2 (de) 4''-deoxyerythromycinderivate
HUP9702448A2 (hu) Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
HUP0105308A2 (hu) Eletriptán-hidrobromid-monohidrát, eljárás az előállítására és a vegyületet tartalmazó gyógyszerkészítmények
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
EP0268223A3 (de) Optisch aktive Gyrasehemmer, ihre Herstellung und Verwendung als Antibiotika
DE69330601D1 (de) Serotoninergische ergolin derivate
RU95107655A (ru) Глюкопиранозидбензотиофены, способ получения, фармацевтическая композиция
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
ATE213410T1 (de) Diclofenac/gamma-cyclodextrin klathrat komponente
NO305560B1 (no) Krystallinsk 3-(4-heksyloksy-1,2,5-tiadiazol-3-yl)-1,2,5,6-tetrahydro-1-metylpyridin-(+)-L-hydrogentartrat, farmas°ytiske preparater som omfatter forbindelsen, samt anvendelse av forbindelsen til fremstilling av et medikament
IT1296613B1 (it) Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.